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Sdescending branch (odds ratio 17,70; 95 percent conﬁdence interval 4,89 to 64,55; p
<0.001) after primary PCI.
Conclusions: Restoration of TIMI ﬂow  2 in all major RV branches during primary
percutaneous coronary intervention, as well as the absence of distal embolization of
the posterior descendent artery, results in lack of cardiovascular magnetic resonance
late enhancement in the right ventricular wall after procedure, regardless of initial
angiographic status.Parameter OR 95% CI p
3-vessel disease 0,433 0,193-0,974 0,043
EF < 50% 0,377 0,160-0,888 0,026
Age > 75 years 0,29 0,114-0,740 0,01
Renal failure 0,259 0,100-0,675 0,006
LM culprit vessel 0,062 0,006-0,601 0,016TCT-225
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Background: The SYNTAX score (SS) has demonstrated strong prognostic utility for
ischemic outcomes in patients undergoing PCI for stable ischemic disease, non-ST-
segment elevation acute coronary syndromes (NSTEACS), and STEMI. We sought to
determine the relationship between the SS and bleeding risk in patients undergoing
percutaneous coronary intervention (PCI) for NSTEACS.
Methods: We stratiﬁed 2,627 patients from the ACUITY in whom PCI was per-
formed into SS groups based on score tertiles (SS <7, 7-12, and >12). Thirty-day
major bleeding rates were determined for each group.
Results: As demonstrated in the Figure, 30-day major bleeding rates were signiﬁ-
cantly greater in the highest SS tertile (>12) compared with intermediate (7-12) and
lowest (<7) tertiles. By multivariable analysis, the SS was independently associated
with 30-day major bleeding (HR per 1 SS point: 1.03, 95% CI: 1.01 to 1.04;
p¼0.003).
Conclusions: In the large-scale ACUITY trial, in addition to its previously described
prognostic utility for adverse ischemic events, the SS was independently associated
with major bleeding after PCI for NSTEACS.TCT-226
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Background: Renal failure (RF) is associated with increased cardiovascular mortality
in patients with acute coronary syndromes (ACS). Nevertheless patients with RF are
less likely to receive reperfusion therapy during AMI. This study is the ﬁrst reportB74 JACC Vol 62/18/Suppl B j October 2from a contemporary randomized controlled trial (RCT) addressing the impact of RF
on long-term clinical outcomes in patients undergoing primary PCI for AMI.
Methods: 745 patients with STEMI underwent primary PCI were enrolled in this
study and were divided in two groups according with the baseline estimated creatinine
clearance (calculated by the use of the Cockcroft-Gault formula) and the National
Kidney Foundation criteria (group A: 176 patients, class III-IV-V; group B: 569
patients, class I-II).
Results: Multivariate logistic regression shows a signiﬁcantly correlation of RF with
3-years cardiovascular death (Table 1). Kaplan-Meier analysis show a signiﬁcantly
decreased of the event-free survival curves for 3-years CV death (log rank <0,001,
Figure 1) in patients with RF.Conclusions: RF is signiﬁcantly associated with 3-years CV death in patients with
AMI treated with successful primary PCI despite no differences in term of treatment
between patients with or without RF.
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Background: Although PPCI has become the preferring reperfusion modality for
STEMI nowadays, thrombolysis remains useful when PPCI will be remarkably
delayed, which is still common in real practice. However, there’re concerns on the
weakness of single thrombolysis, especially re-occlusion of the vessel. It has been
suggested that early PCI after thrombolysis might improve its efﬁcacy. We used CMR
to further investigate this “pharmacoinvasion” strategy.
Methods: Current data came from an ongoing RCT comparing pharmacoinvasion and
PPCI for STMEI within 12h. Pharmacoinvasion was composed of r-TPA thrombolysis
and angiography/PCI 3-24h thereafter except for thrombolysis failure, in which
situation a rescue PCI would be done immediately. CMR was performed 2-8d after
reperfusion.
Results: 51 in pharmacoinvasion and 49 patients in PPCI group received CMR assay,
representing 80.1% of total patients. Rate of successful thrombolysis was 84.4%
(TIMI ﬂow grades2 in culprit artery). Median time between thrombolysis and
angiography was 7.7h (3.6 to 16.5h). 49 in pharmacoinvasion and all patients in PPCI
group received stenting. Symptom-to-CMR time and other baseline characteristics
were similar except for door-to-reperfusion time (door-to-needle/door-to-balloon time
for thrombolysis/PPCI), which was signiﬁcantly shorter in pharmacoinvasion group
(4422min vs. 8641min, p<0.001). Most of the CMR results were statistically
equal between pharmacoinvasion and PPCI arms: LVEF 52.210.7% vs. 4911.7%,
p¼0.167; Intramyocardial hemorrhage 43.1% vs. 48.9%, p¼0.548; Microvascular
obstruction (MVO) 64.7% vs. 65.3%, p¼1.000; MVO size (proportion to LV
myocardium) 2.02.8% vs. 2.12.9%, p¼0.818. However, infarction size (pro-
portion to LV myocardium) was signiﬁcantly lower in pharmacoinvasion group:
23.512.3% vs. 29.716.2%, p¼0.034.
Conclusions: Current CMR data suggested that pharmacoinvasion strategy may have
comparable efﬁcacy as PPCI. Much shorter door-to-reperfusion time showing in this7–November 1, 2013 j TCT Abstracts/POSTER/STEMI/NSTEMI/ACS
